English
TitleLandiolol, an Ultra-short Acting ƒÀ1-Adrenoreceptor Antagonist, for Treatment of an Abrupt Tachycardia in Patients Undergoing Total Knee Arthroplasty under General Anesthesia
Subtitle
AuthorsMariko Adachi, Takashi Horiguchi, Toshiaki Nishikawa
Authors(kana)
OrganizationDepartment of Anesthesia and Intensive Care Medicine, Akita University Graduate School of Medicine
JournalCirculation Control
Volume33
Number2
Page104-111
Year/Month2012/8
ArticleOriginal article
PublisherJapan Society of Circulation Control in Medicine
Abstract[Abstract] Tachycardia and hypertension due to surgical and tourniquet pain often occur suddenly during general anesthesia for total knee arthroplasty. We evaluated the dose-related effects of landiolol on an abrupt tachycardic response in this clinical setting, since this agent is able to suppress the cardiovascular responses associated with sympathetic stimulation. After approval by the local ethical committee and informed consent, 114 patients, aged 51-89 yr, undergoing total knee arthroplasty under general anesthesia were enrolled in this study. Following general anesthesia induction with fentanyl 1-2 ƒÊg/kg, propofol 1.5-2 mg/kg and 5% sevoflurane, a laryngeal mask airway was inserted, and anesthesia was maintained with 1% sevoflurane, droperidol 5 mg and 50% N2O in oxygen. Thereafter, supplemental fentanyl 0.5-1 ƒÊg/kg was injected repeatedly to keep the end-tidal CO2 tension of 30-45 mmHg, and spontaneous respiratory rate of 10-25 breaths/min. When a tachycardic response (defined as heart rate of more than 90 beats/min for more than 3 minutes) was observed, landiolol or normal saline (as a time control group) was randomly infused continuously at a rate of 40 or 80 ƒÊg/kg/min, or of 0.24 mL/kg/h, respectively, until the end of surgery or tourniquet deflation. Hemodynamic and respiratory variables were recorded at 1-5 minute intervals. Data were analyzed by analysis of variance or Student's t-test with Bonferroni's correction for comparisons among groups or within each group, with p<0.05 being significant. Tachycardic responses developed in 50 of 114 patients (44%) studied. There were no significant differences in demographic data among patients who received landiolol 40 ƒÊg/kg/min (n=24), landiolol 80 ƒÊg/kg/min (n=20), and saline (n=6). Heart rate decreased at 1 minute after the start of landiolol infusion and remained below pre-administration values (p<0.05) in patients receiving landiolol 40 and 80 ƒÊg/kg/min, while heart rate unchanged in control patients. Mean blood pressure remained unchanged as compared with pre-infusion values in all groups. When compared with the control group, heart rate was lower 5 and 4 minutes after the start of landiolol infusion (p<0.05) in patients given landiolol of 40 and 80 ƒÊg/kg/min, respectively. These data show that landiolol infusion at a rate of 80 ƒÊg/kg/min provided more rapid suppression of an abrupt tachycardia in patients undergoing total knee arthroplasty under general anesthesia. The prompt treatment of tachycardia by landiolol seems appropriate, particularly for the older patients who are likely to have occult ischemic heart disease.
PracticeBasic medicine
Keywordslandiolol, tachycardia, total knee arthroplasty, ultra-short-acting ƒÀ1-selective adrenoreceptor antagonist

y‘S•¶PDFz